시장보고서
상품코드
1985929

방사선 정보 시스템 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 배포 모드별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Radiology Information Systems Market Size, Share & Trends Analysis Report By Product, By Deployment Mode, By End Use, By Region, And Segment Forecasts, 2026 - 2033

발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ₩ 8,861,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ₩ 10,350,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ₩ 13,329,000
카드담기
※ 부가세 별도
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

방사선 정보 시스템 시장 요약

세계의 방사선 정보 시스템(RIS) 시장 규모는 2025년에 11억 9,000만 달러로 평가되며, 2033년까지 26억 4,000만 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 10.49%로 성장할 전망입니다.

RIS 이용을 촉진하기 위한 정부 주도의 노력이 확대되면서 의료 인프라에 대한 투자가 증가하고 있습니다.

또한 방사선 의학 전문가와 클리닉의 수가 증가함에 따라 업계내 클라우드 기반 솔루션에 대한 수요가 증가하고 있습니다. 또한 암, COPD(만성폐쇄성폐질환), 관절염, 골다공증 등 만성질환을 앓고 있는 환자 수가 최근 들어 크게 증가하고 있습니다. 이로 인해 의료 영상 진단에 대한 수요가 증가하고 있으며, 이는 방사선 정보 시스템(RIS) 시장의 성장을 촉진하고 있습니다. 전산화된 의료 영상은 의료의 각 부서 간에 접근 가능한 안전하고 편리한 양방향 문서를 제공합니다.

방사선 정보 시스템(RIS)은 주치의와 영상 진단 부서 간의 소통의 가교 역할을 하며, 보다 나은 진료 협진을 촉진하여 환자의 적시 진단과 치료에 도움을 주고 있습니다.

방사선 검사 건수 증가와 이러한 서비스에 대한 접근성 향상에 따라 수요를 충족시키기 위한 새로운 시스템이 개발되고 있습니다. 예를 들어 2025년 6월 CIVIE는 인공지능(AI)을 활용한 온디맨드 방사선 진단 플랫폼 'RadPod'를 출시했습니다. 이를 통해 영상의학과 전문의는 언제 어디서나 스캔 영상을 진단할 수 있고, 실시간으로 보상을 받을 수 있습니다. AI 탑재 PACS, 음성 인식, 즉시 결제, 커스터마이징 가능한 워크리스트, 웹 접속, 자동 품질관리(QA) 등의 기능을 갖추고 있습니다. 또한 병원에서는 업무 효율을 높이기 위해 클라우드 기술 및 관련 서비스를 점점 더 많이 이용하고 있습니다.

"방사선 의학 전체가 지난 수십년간 어려운 문제에 직면해 왔습니다. 영상의학과 의사는 교대근무나 일정에 얽매이거나, 기술적 격차나 의뢰의사의 불명확한 요구와 같은 비효율적인 요소로 인해 방해받는 것을 원하지 않습니다. CIVIE는 수십 년간의 영상의학 경험을 집약하여 영상의학과 의사들이 갈망하던 것, 즉 자신의 의지와 조건에 따라 자유롭게 의료영상을 판독할 수 있는 최첨단 솔루션을 제공합니다. "

CIVIE CEO,Dhruv Chopra

또한 의료기관의 대규모 투자가 시장 성장을 촉진하고 있습니다. 예를 들어 2024년 6월 코니카 미놀타 헬스케어 아메리카(Konica Minolta Healthcare Americas)는 아폴로 기업 이미징(Apollo Enterprise Imaging Corp.)과 제휴하여 '엑사 플랫폼(Exa Platform)'을 제공하기 시작했습니다. 이 플랫폼은 RIS, PACS 및 청구 솔루션을 모든 모듈에 걸쳐 단일 데이터베이스로 통합하고 있습니다. 이 솔루션은 Arc를 통해 전사적으로 임상 컨텐츠를 안전하게 관리, 획득 및 액세스할 수 있도록 지원하며, 모든 임상 부서의 연결성과 상호운용성을 향상시켜 고객에게 혜택을 제공합니다. 이번 제휴는 비 DICOM 장비를 포함한 임상 전문 분야를 넘나들며 환자 정보를 통합하고, 영상에 대응하는 종합적인 전자의무기록(EMR)을 구축하는 것을 목표로 하고 있습니다.

자주 묻는 질문

  • 방사선 정보 시스템(RIS) 시장 규모는 어떻게 예측되나요?
  • 방사선 정보 시스템(RIS) 시장의 성장을 촉진하는 요인은 무엇인가요?
  • CIVIE의 RadPod 플랫폼은 어떤 기능을 제공하나요?
  • 코니카 미놀타 헬스케어 아메리카의 엑사 플랫폼은 어떤 특징이 있나요?
  • 방사선 정보 시스템(RIS)의 역할은 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 변수, 동향, 범위

제4장 방사선 정보 시스템 시장 : 배포 모드별 추정·동향 분석

제5장 방사선 정보 시스템 시장 : 제품별 추정·동향 분석

제6장 방사선 정보 시스템 시장 : 최종 용도별 추정·동향 분석

제7장 방사선 정보 시스템 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도

KSA 26.04.23

Radiology Information Systems Market Summary

The global radiology information systems market size was valued at USD 1.19 billion in 2025 and is projected to reach USD 2.64 billion by 2033, growing at a CAGR of 10.49% from 2026 to 2033. Growing government initiatives to promote the use of RIS have resulted in increased investments in healthcare infrastructure.

In addition, the number of radiology professionals and practices has increased, and there is a growing preference for cloud-based solutions in the industry. Moreover, the number of patients suffering from chronic diseases such as cancer, COPD, arthritis, osteoporosis, and others has increased significantly in recent years. This is increasing the demand for medical imaging, thereby driving the radiology information system (RIS) market growth. Computerized medical imaging provides secure and convenient interactive documents that can be accessed across various healthcare departments.

Radiology Information System (RIS) serves as a communication link between primary physicians and imaging departments, facilitating better care coordination, which is beneficial for the timely diagnosis or treatment of the patients.

The rising number of radiology procedures and increased accessibility to these services have led to the development of new systems to meet the demand. For instance, in June 2025, CIVIE launched RadPod, an artificial intelligence (AI)-driven on-demand radiology platform that enables radiologists to interpret scans anytime, anywhere, with real-time compensation. Features AI-powered PACS, voice recognition, instant payments, custom worklists, web access, and automated QA. Furthermore, hospitals are increasingly using cloud technology and related services to improve operational efficiency.

"Radiology as a whole has been facing brutal challenges for the past couple of decades. Radiologists don't want to be bound by shifts and schedules or hindered by inefficiencies like technology gaps and unclear requirements from referring physicians. By bringing together our decades of radiology experience, CIVIE delivers what radiologists have been craving: a state-of-the-art solution that allows them to read medical scans at will and on their terms."

Dhruv Chopra, CEO of CIVIE.

In addition, substantial investments by medical institutions are boosting market growth. For instance, in June 2024, Konica Minolta Healthcare Americas partnered with Apollo Enterprise Imaging Corp. to provide the Exa Platform. This platform integrates RIS, PACS, and Billing solutions with a single database across all modules. The solution enables secure management, acquisition, and access of clinical content throughout the enterprise via Arc, benefiting customers with improved connectivity and interoperability across all clinical departments. The partnership aims to unify patient information across clinical specialties, including non-DICOM devices, to create a comprehensive, image-enabled electronic medical record (EMR).

Global Radiology Information Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the global radiology information systems (RIS) market report based on deployment mode, product, end use, and region:

  • Deployment Mode Outlook (Revenue, USD Million, 2018 - 2033)
  • Web-based
  • Cloud-based
  • On-premise
  • Product Outlook (Revenue, USD Million, 2018 - 2033)
  • Integrated RIS
  • Standalone RIS
  • End Use Outlook (Revenue, USD Million, 2018 - 2033)
  • Hospitals & Clinics
  • Outpatient Department (OPD) Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • The Netherlands
    • Switzerland
    • Belgium
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • Singapore
    • Philippines
    • Malaysia
    • Indonesia
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Deployment Mode
    • 1.2.2. Product
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in mergers and acquisitions of healthcare providers
      • 3.2.1.2. Rise in the aging population
      • 3.2.1.3. Increase in cloud computing and web-based solutions
      • 3.2.1.4. Increase in number of chronic diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High threat of data breaching
      • 3.2.2.2. High cost of implementation
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Threat Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Radiology Information Systems Market: Deployment Mode Estimates & Trend Analysis

  • 4.1. Deployment Mode Segment Dashboard
  • 4.2. Deployment Mode Market Share Movement Analysis, 2023 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2018 to 2033 (USD Million)
  • 4.4. Web-based
    • 4.4.1. Web-based market, 2018 - 2033 (USD Million)
  • 4.5. Cloud-based
    • 4.5.1. Cloud-based market, 2018 - 2033 (USD Million)
  • 4.6. On-premise
    • 4.6.1. On-premise market, 2018 - 2033 (USD Million)

Chapter 5. Radiology Information Systems Market: Product Estimates & Trend Analysis

  • 5.1. Product Segment Dashboard
  • 5.2. Product Market Share Movement Analysis, 2023 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2033 (USD Million)
  • 5.4. Integrated RIS
    • 5.4.1. Integrated RIS market, 2018 - 2033 (USD Million)
  • 5.5. Standalone RIS
    • 5.5.1. Standalone RIS market, 2018 - 2033 (USD Million)

Chapter 6. Radiology Information Systems Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. End Use Market Share Movement Analysis, 2023 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by end use, 2018 to 2033 (USD Million)
  • 6.4. Hospitals & Clinics
    • 6.4.1. Hospitals & Clinics market, 2018 - 2033 (USD Million)
  • 6.5. Outpatient Department (OPD) Clinics
    • 6.5.1. Outpatient Department (OPD) Clinics market, 2018 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market, 2018 - 2033 (USD Million)

Chapter 7. Radiology Information Systems Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamic
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive insights
      • 7.3.2.4. U.S. RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamic
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive insights
      • 7.3.3.4. Canada RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamic
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive insights
      • 7.3.4.4. Mexico RIS market estimates and forecasts, 2018 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. UK RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. Germany RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. France RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.5. Russia
      • 7.4.5.1. Key country dynamic
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive insights
      • 7.4.5.4. Russia RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.6. Italy
      • 7.4.6.1. Key country dynamic
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive insights
      • 7.4.6.4. Italy RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.7. Spain
      • 7.4.7.1. Key country dynamic
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive insights
      • 7.4.7.4. Spain RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.8. Netherlands
      • 7.4.8.1. Key country dynamic
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive insights
      • 7.4.8.4. Netherlands RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.9. Switzerland
      • 7.4.9.1. Key country dynamic
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive insights
      • 7.4.9.4. Switzerland RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.10. Belgium
      • 7.4.10.1. Key country dynamic
      • 7.4.10.2. Regulatory framework
      • 7.4.10.3. Competitive insights
      • 7.4.10.4. Belgium RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.11. Norway
      • 7.4.11.1. Key country dynamic
      • 7.4.11.2. Regulatory framework
      • 7.4.11.3. Competitive insights
      • 7.4.11.4. Norway RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.12. Denmark
      • 7.4.12.1. Key country dynamic
      • 7.4.12.2. Regulatory framework
      • 7.4.12.3. Competitive insights
      • 7.4.12.4. Denmark RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.4.13. Sweden
      • 7.4.13.1. Key country dynamic
      • 7.4.13.2. Regulatory framework
      • 7.4.13.3. Competitive insights
      • 7.4.13.4. Sweden RIS market estimates and forecasts, 2018 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Japan RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. China RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. India RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. South Korea RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Australia RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Thailand RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.8. Singapore
      • 7.5.8.1. Key country dynamic
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive insights
      • 7.5.8.4. Singapore RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.9. Philippines
      • 7.5.9.1. Key country dynamic
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive insights
      • 7.5.9.4. Philippines RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.10. Malaysia
      • 7.5.10.1. Key country dynamic
      • 7.5.10.2. Regulatory framework
      • 7.5.10.3. Competitive insights
      • 7.5.10.4. Malaysia RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.5.11. Indonesia
      • 7.5.11.1. Key country dynamic
      • 7.5.11.2. Regulatory framework
      • 7.5.11.3. Competitive insights
      • 7.5.11.4. Indonesia RIS market estimates and forecasts, 2018 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Brazil RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. Argentina RIS market estimates and forecasts, 2018 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. South Africa RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Saudi Arabia RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamic
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive insights
      • 7.7.4.4. UAE RIS market estimates and forecasts, 2018 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamic
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive insights
      • 7.7.5.4. Kuwait RIS market estimates and forecasts, 2018 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Veradigm LLC
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Service benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. Oracle
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Service benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Epic Systems Corporation
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Service benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Mckesson Corporation
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Service benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. DeepHealth
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Service benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Siemens Healthineers AG
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Service benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Koninklijke Philips N.V.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Service benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Pro Medicus, Ltd.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Service benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. MedInformatix, Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Service benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. GE Healthcare
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Service benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Merative
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Service benchmarking
      • 8.5.11.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제